Your browser doesn't support javascript.
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses.
Pettini, Elena; Ciabattini, Annalisa; Pastore, Gabiria; Polvere, Jacopo; Lucchesi, Simone; Fiorino, Fabio; Montagnani, Francesca; Bucalossi, Alessandro; Tozzi, Monica; Marotta, Giuseppe; Medaglini, Donata.
  • Pettini E; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, and.
  • Ciabattini A; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, and.
  • Pastore G; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, and.
  • Polvere J; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, and.
  • Lucchesi S; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, and.
  • Fiorino F; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, and.
  • Montagnani F; Department of Medical Biotechnologies, University of Siena, Siena, Italy; and.
  • Bucalossi A; Department of Medical Sciences, Infectious and Tropical Diseases Unit, and.
  • Tozzi M; Cellular Therapy Unit, Department of Innovation, Experimentation, Clinical and Translational Research, University Hospital of Siena, Siena, Italy.
  • Marotta G; Cellular Therapy Unit, Department of Innovation, Experimentation, Clinical and Translational Research, University Hospital of Siena, Siena, Italy.
  • Medaglini D; Cellular Therapy Unit, Department of Innovation, Experimentation, Clinical and Translational Research, University Hospital of Siena, Siena, Italy.
Blood Adv ; 6(7): 2247-2249, 2022 04 12.
Artigo em Inglês | MEDLINE | ID: covidwho-1650948

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tópicos: Vacinas Limite: Humanos Idioma: Inglês Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tópicos: Vacinas Limite: Humanos Idioma: Inglês Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Artigo